Diabetes drug holds promise to slow Parkinson’s progression

04:22 EDT 4 Aug 2017 | Pharmafile

There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will become increasingly urgent as ageing populations mean that more people will be diagnosed with the condition.

A breakthrough piece of research that has found a repurposed use for a diabetes drug that could slow down the progression of the disease has been welcomed by scientists and charity groups.

read more

Original Article: Diabetes drug holds promise to slow Parkinson’s progression


More From BioPortfolio on "Diabetes drug holds promise to slow Parkinson’s progression"

Quick Search

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...